Solana memecoin WhiteWhale plunged 60% after a $1.3m token selloff, as on-chain data tracks whale exits and CoinGecko flags 2025 as a record year for token failuresSolana memecoin WhiteWhale plunged 60% after a $1.3m token selloff, as on-chain data tracks whale exits and CoinGecko flags 2025 as a record year for token failures

WhiteWhale bulls face 60% wipeout after $1.3m Solana meme coin dump

2026/01/20 18:30
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Solana memecoin WhiteWhale plunged 60% after a $1.3m token selloff, as on-chain data tracks whale exits and CoinGecko flags 2025 as a record year for token failures.

Summary
  • WhiteWhale, a community-driven Solana memecoin launched on Pump.fun, crashed 60% after large holders sold about $1.3m in tokens, wiping out market cap within minutes.​
  • On-chain data shows trader Remus bought 1.5% of supply early, took profits into the rally but still holds a sizable stack, while the team frames the event as “liquidity distribution.”​
  • CoinGecko reports over half of all cryptocurrencies have failed, with 11.6m token deaths in 2025 alone and Q4 marking a historic wipeout led by memecoins.

WhiteWhale, a community-driven Solana meme coin, experienced a 60% price decline following accusations of a rug pull and a $1.3 million token sale by large holders, according to on-chain data.

Solana memecoin WhiteWhale plunges 60%

The token, launched three months ago on the Pump.fun platform, witnessed significant selling activity on Monday that caused its market capitalization to decline within minutes, according to blockchain data. The event resulted in substantial losses for token holders.

Market analyst Darky flagged the price crash on social media, noting the rapid decline of the viral memecoin. Blockchain data indicates that a trader identified as Remus purchased 1.5% of the total token supply at a low price point. The position appreciated in value during a subsequent rally before Remus sold a portion of the holdings, contributing to the price decline.

Remus continues to hold a substantial amount of WhiteWhale tokens despite the decreased valuation, according to on-chain records. Members of the WhiteWhale community characterized the event as a planned liquidity distribution designed to broaden token ownership and mitigate concentration risks.

The token showed partial recovery by Tuesday, according to market data.

A recent analysis by CoinGecko reported that more than 50% of cryptocurrencies have failed. The report stated that millions of tokens failed in 2025 alone, representing a majority of token failures. Memecoins experienced significant pressure from broader market volatility throughout the year, resulting in decreased token survivability rates.

The fourth quarter of 2025 recorded the collapse of millions of tokens, constituting a significant portion of all documented project failures, according to the CoinGecko report. The year 2024 saw nearly 1.4 million project failures, accounting for a notable share of all failures over the past five years, the report stated.

Market Opportunity
The White Whale Logo
The White Whale Price(WHITEWHALE)
$0.04815
$0.04815$0.04815
-2.64%
USD
The White Whale (WHITEWHALE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09